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bDITORIAL COMMENT
ostexercise Severe Ventricular
ctopy in Heart Failure Patients
ew Marker for Aggregate Risk*
aniel L. Dries, MD, MPH,†
alph J. Verdino, MD, FACC,‡
obert C. Kowal, MD, PHD†
allas, Texas; and Philadelphia, Pennsylvania
n our current era marked with the beneficial addition of
mplantable cardiac defibrillators (ICDs) and beta-
drenergic receptor blockade to our therapeutic strategies, it
s increasingly difficult to identify the individual with
dvanced systolic heart failure (HF) at high mortality risk
1). Traditionally, the peak maximum oxygen consumption
dentified during symptom-limited, metabolic exercise
readmill testing has been considered one of the best criteria
s originally identified by Mancini et al. (2). However, in
he current era of beta-blocker treatment for advanced HF,
here are developing concerns regarding the interpretation
f this marker in identifying the high-risk individual. For
xample, Shaker et al. (3), in a retrospective analysis,
emonstrated that the traditional peak oxygen-consumption
ut-off value of 14 ml/kg/min does not predict survival free
f cardiac transplant in patients who tolerate chronic treat-
ent with beta-adrenergic receptor blockers. Therefore, it is
oth important and relevant to identify new clinical markers
f aggregate risk to assist in this decision-making process.
See page 820
In a retrospective, cohort study in this issue of the Journal,
’Neill et al. (4) demonstrate that the presence of complex
entricular ectopy during the recovery period after
ymptom-limited metabolic exercise treadmill testing iden-
ifies patients with advanced HF at increased risk for
ll-cause mortality. In a total of 2,123 consecutive patients
ndergoing routine symptom-limited metabolic exercise
readmill testing at the Cleveland Clinic, the three-year
ortality ascertained from the Social Security Death Index
as greater in patients who developed severe ventricular
ctopy during recovery compared with those who did not
37% vs. 22%; p  0.0001). Severe ventricular ectopy was
efined as the presence of ventricular triplets, sustained or
onsustained ventricular tachycardia, ventricular flutter, poly-
orphic ventricular tachycardia, or ventricular fibrillation.
*Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
From †Division of Cardiology, UT Southwestern Medical Center, Dallas, Texas;
nd ‡Division of Cardiology, Hospital of the University of Pennsylvania, Philadel-
thia, Pennsylvania.The prevalence of severe ventricular ectopy during recov-
ry from exercise was relatively low, as only 140 of 2,123
7%) of the consecutive patients who were analyzed experi-
nced this phenomenon. The groups with and without
entricular ectopy during recovery from metabolic exercise
readmill testing were reasonably balanced with regards to
otential confounders. The group with severe ventricular
ctopy during recovery was significantly older (57 vs. 54
ears) and had more chronic obstructive pulmonary disease
15% vs. 9%). Medical therapy was balanced with the
xception of less use of amiodarone in the group with severe
ctopy during recovery (14% vs. 22%). Importantly, beta-
locker use was not significantly different (38% vs. 44%)
etween the groups. The etiology of advanced HF appeared
alanced based on the presence of known coronary artery
isease (50% vs. 51%). Moreover, the severity of HF also
ppeared balanced between those with and without severe
entricular ectopy during recovery, as suggested by similar
ean ejection fractions (19% vs. 20%), systolic blood
ressure (108 mm Hg vs. 109 mm Hg), and peak oxygen
onsumption (16.5  4.3 ml/kg/min vs. 16.5  5.2 ml/kg/
in) in patients with severe ventricular ectopy compared
ith those without severe ventricular ectopy during recovery
rom exercise.
The association of severe ventricular ectopy during recov-
ry from exercise persisted in adjusted analysis (hazard ratio
HR] 1.48; 95% confidence interval [CI] 1.10 to 1.97; p 
.0089). In stratified analyses, the association of ventricular
ctopy was observed in those using (HR 1.81; 95% CI 1.00
o 3.28) and not using beta-blockers (HR 1.68; 95% CI 1.21
o 2.34), patients with a nonischemic (HR 1.99; 95% CI
.32 to 2.99) and ischemic etiologies (HR 1.63; 95% CI
.08 to 2.46), as well as those with (HR 2.25; 95% CI 1.16
o 4.35) and without (HR 1.45; 95% CI 1.00 to 2.11) severe
entricular ectopy during exercise. The only hint for inter-
ction (p  0.05) was demonstrated when the analysis was
tratified by peak oxygen consumption using the traditional
ut-off value for transplant consideration. The association of
evere postexercise ventricular ectopy with increased mor-
ality risk was most robust in those with a peak oxygen
onsumption 14 ml/kg/min (HR 2.28; 95% CI 1.57 to
.32) as compared with those 14 ml/kg/min (HR 1.26;
5% CI 0.80 to 1.99).
Arrhythmias in the setting of left ventricular dysfunction
ay be due to re-entry, may be triggered after-depolarizations,
r due to enhanced automaticity. It is more likely that alter-
tions in autonomic tone may explain the frequency and type of
rrhythmia observed in patients during the recovery phase of
tress testing. High vagal tone has long been associated with a
ecreased propensity to malignant ventricular tachyarrhyth-
ias and a prolonged survival in patients with cardiac disease
5). Heart rate response during the recovery period of stress
esting is believed to be a marker of autonomic tone and has
een shown to be predictive of mortality (6). In a study of more
han 29,000 patients without a history of HF or arrhythmias,
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Editorial Comment August 18, 2004:827–8entricular arrhythmias during the recovery phase of stress
esting also were found to be a good predictor of mortality (7).
he current study extends this finding to patients with con-
estive HF. Finally, interventricular and intraventricular con-
uction delay may contribute to impaired autonomic tone as
uggested by improvements in heart rate variability after
ardiac resynchronization therapy (8).
One may question the relevance of these data to current
ractice because many of the patients in this study with an
schemic etiology would now be candidates for ICDs based of
he results of the Multicenter Automatic Defibrillator Implan-
ation Trial (MADIT), the Multicenter UnSustained Tachy-
ardia Trial (MUSTT) and the MADIT-II studies. Moreover,
iven the recently released results of Sudden Cardiac Death-
eart Failure Trial (SCD-HeFT), it appears that ICD therapy
ill be recommended for all patients with symptomatic HF,
ncluding those with a nonischemic etiology. Diminishing the
linical relevance of the present study by O’Neill et al. (4) based
n this line of reasoning assumes, however, that severe ven-
ricular ectopy during recovery from metabolic exercise testing
dentifies patients with an increased risk for arrhythmic death
hat would be substantially reduced by an ICD. However, the
ssociation of severe ventricular ectopy during recovery from
etabolic exercise testing with an increased risk for mortality
as demonstrated in patients with (HR 1.91; 95% CI 1.01 to
.60) and without (HR 1.75; 95% CI 1.26 to 2.42) an ICD.
hat does this suggest? It is likely that the presence of severe
entricular ectopy during recovery is not a marker of future
rrhythmic risk as much as an aggregate measure of HF
everity that identifies patients at higher risk for disease
rogression. Impaired baroreceptor function certainly is ex-
ected to contribute to arrhythmic risk, but its presence also
eflects a globally disturbed pathophysiologic milieu that likely
ncreases overall mortality risk. For example, reduced heart rate
ariability, another measure of impaired baroreceptor function,
redicts not only sudden but also all-cause mortality in patients
ith HF (9,10). Moreover, a precise understanding of the
echanism(s) involved is not necessary for it to function as a
seful “summary index” of risk. In addition, although there are
myriad of markers that have been associated with an
ncreased relative risk for adverse outcomes in HF, the clinician
aring for a patient needs to have an estimate of absolute risk.
he three-year mortality rate experienced by the overall group
f patients that developed severe ventricular ectopy during
ecovery was greater than what would be expected with cardiac
ransplantation. However, because this included all the patients
hat experienced severe ventricular ectopy during recovery from
xercise, it is not certain from the data presented that this poor
ctuarial survival was experienced by the group with a peak
xygen consumption 14 ml/kg/min.
The increasing challenge to clinicians managing patients
ho have advanced HF is to improve our capacity to risk
tratify these patients in the era of cardiac defibrillators, cardiac
esynchronization therapy, and the addition of beta-blockers to
he therapeutic armamentarium. Another challenge is to de-
ermine the best management for patients tolerating beta-locker therapy who have peak oxygen consumption values
hat ordinarily would trigger consideration for a cardiac trans-
lant. Ideally, one would like to see these data confirmed in a
ohort of patients receiving contemporary management of their
eart failure. In particular, it would be desirable to validate
hese findings in patients with a peak oxygen consumption
14 ml/kg/min, a group that is usually considered to have a
ood prognosis. However, although acknowledging the inher-
nt weaknesses in a retrospective analysis of a cohort assembled
ver a time period of evolving changes in HF therapy, these
ata are intriguing and appear to identify a novel and easily
scertained aggregate risk marker with the capacity to improve
ur ability to identify the high-risk patient with advanced HF.
t seems reasonable to conclude that presence or absence of
omplex ventricular ectopy during recovery after metabolic
xercise testing identifies the individual patient who warrants
ore frequent follow-up than would otherwise be considered,
n particular those with a peak oxygen consumption 14
l/kg/min, optimization of pharmacological treatment, and
ossibly cardiac resynchronization therapy (8) if significant
nterventricular or intraventricular conduction delay is present.
inally, the presence of this aggregate risk marker might be
seful to adjudicate clinical equipoise in patients who are
therwise at the threshold of consideration for cardiac trans-
lantation.
eprint requests and correspondence: Dr. Daniel L. Dries, Heart
ailure Research Unit, Division of Cardiology, University of Texas
outhwestern Medical Center, Dallas, Texas 75390. E-mail:
aniel.dries@utsouthwestern.edu
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